Antiviral agent
US4868162A · kind A · utility
14Cited by
2References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 23, 1987 |
| Grant date | Sep 19, 1989 |
| Priority date | — |
| Expiry date | Mar 23, 2007 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A method of inhibiting viral replication in a cell comprising administering an effective amount of an esterified derivative of 5-halogenated-2'-deoxy-uridine expressed by the following formula (I) ##STR1## wherein X represents any one of F, Cl, and Br; R.sup.1 and R.sup.2 may be identical or different from each other, each representing an aliphatic acyl group comprising two or more carbon atoms or an aromatic acyl group comprising 7 or more carbon atoms.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.